Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04911478 · ClinicalTrials.gov registry record
Long-term Follow-up Study of Allogeneic Gamma Delta (γδ) CAR T Cells
A clinical trial, sponsored by Adicet Therapeutics.
- Active
- Registry status
- 50
- Enrollment target
NCT04911478 is a clinical trial that is active but no longer recruiting, run by Adicet Therapeutics. The registered enrollment target is 50 participants.
The verdict
NCT04911478 is active but no longer recruiting, sponsored by Adicet Therapeutics.
- ACTIVE NOT RECRUITING
- Registry status
- 50 participants
- Enrollment target
Study Summary
The purpose of this study is to assess long-term side effects from subjects who receive an Adicet Bio γδ CAR T cell product. Subjects will join this study once they complete the parent interventional study. No additional study drug will be given, but subjects can receive other therapies for their cancer while they are being followed for long term safety in this study. For a period of 15 years from the first administration of Adicet Bio allogeneic γδ CAR T cell product, subjects will be assessed for long-term safety and survival through collection of data that include safety, efficacy, pharmacokinetics and immunogenicity.
Interventions
- GENETIC ADI-001
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2022-02-14 |
| Est. Completion | 2039-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04911478
The ClinicalTrials.gov registry entry for NCT04911478 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Adicet Therapeutics, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which ADI-001 is the first listed.
NCT04911478 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04911478 about?
NCT04911478 is a clinical study titled "Long-term Follow-up Study of Allogeneic Gamma Delta (γδ) CAR T Cells". The purpose of this study is to assess long-term side effects from subjects who receive an Adicet Bio γδ CAR T cell product. Subjects will join this study once they complete the parent interventional study. No additional study drug will be given, but subjects can receive other therapies for their ca...
What is the current status of trial NCT04911478?
This trial is currently active not recruiting. The enrollment target is 50 participants. The study started on 2022-02-14. Estimated completion is 2039-08.
What interventions are being tested in trial NCT04911478?
The interventions under investigation include: ADI-001 (GENETIC).
Who is sponsoring clinical trial NCT04911478?
This trial is sponsored by Adicet Therapeutics, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.